Quantitative PCR (qPCR) Market Size and Trends Report | 2031

Quantitative PCR (qPCR) Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (One-Step qPCR and Two-Step qPCR), Product (Instruments, Reagents and Consumables, and Software and Services), Application (Research, Clinical, and Forensics), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

  • Report Code : TIPRE00039035
  • Category : Biotechnology
  • Status : Data Released
  • No. of Pages : 150
Buy Now

The quantitative PCR (qPCR) market size is projected to reach US$ 4.82 billion by 2031 from US$ 2.57 billion in 2023; the market is estimated to record a CAGR of 8.2% during 2023–2031.

qPCR, also known as real-time PCR, allows users to monitor the progress of a PCR in real time. Employing qPCR allows professionals to calculate PCR amplification simultaneously as the reaction proceeds. qPCR is an extensively used diagnostic technique in diverse sectors such as research, pharmaceuticals, and biotechnology. The demand for molecular testing is fueled by technological advancements in PCR systems, and the need for accurate and reliable cancer biomarker detection processes. Technological advancements in qPCR technologies and the growing demand for qPCR in infectious disease diagnosis are further projected to propel the growth of the market in the coming years. The quantitative PCR (qPCR) market trends include the integration of artificial intelligence and data analysis.

Growth Drivers:

PCR has become a crucial tool for various clinical and diagnostic applications or examinations. Relative simplicity, exquisite sensitivity, and cost-effectiveness are among the noteworthy advantages of PCR that have tremendously increased the use of PCR technology in the past years. It is a robust and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and single nucleotide variation analysis. It also serves as the basis for most next-generation sequencing (NGS) preparation. Technological advancements are producing different types of PCR techniques. In particular, high-tech real-time PCR or qPCR systems are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Since its development, qPCR has grown to be an essential component of molecular biology and is widely used in research, clinical diagnostics, and testing for food safety. Its major advantages are rooted in the quantification and viral strain genotyping abilities it offers to users, enabling the estimation of reinfection based on the quantity of virus present in target tissues. It has transformed the field of nucleic acid detection and quantification, allowing researchers and medical professionals to analyze genes, mutations, and genetic variants in unprecedented detail.

CRISPR-based qPCR, automated qPCR systems, multiplex qPCR, and next-generation qPCR are examples of recent advancements in qPCR technology. With improved sensitivity, specificity, and accuracy, these systems broaden the application of qPCR in clinical diagnosis, research, and food safety testing, among other applications. Multiple target sequences can be detected and quantified in a single reaction using multiplex qPCR, saving time and reducing sample requirements. This method is useful for pathogen detection, gene expression profiling, and genetic variation analysis. In addition, next-generation qPCR helps detect and quantify nucleic acid sequences in an array of samples using cutting-edge sequencing technologies. This technique has a high degree of sensitivity and accuracy for detecting low-abundance target sequences. With careful consideration of primer design, optimization, and sample preparation, qPCR analysis can yield valuable insights into gene expression, disease diagnosis, and food safety testing. Thus, technological advancements in PCR technologies are contributing to the quantitative PCR (qPCR) market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Quantitative PCR (qPCR) Market: Strategic Insights

Quantitative PCR (qPCR) Market

  • CAGR (2023 - 2031)
    8.2%
  • Market Size 2023
    US$ 2.57 Billion
  • Market Size 2031
    US$ 4.82 Billion

Market Dynamics

GROWTH DRIVERS
  • Growing Demand of qPCR for Detecting Infectious Diseases
  • Technological Advancements in PCR Technologies
FUTURE TRENDS
  • Integration of Artificial Intelligence and Data Analysis
OPPORTUNITIES
  • Rising Strategic Initiatives by Companies

Key Players

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Standard Biotools Inc.
  • F. Hoffmann-la Roche Ltd
  • Qiagen
  • Lepu Medical Technology Beijing Co Ltd
  • Bio-rad Laboratories Inc.
  • Takara Bio Inc.
  • Agilent Technologies Inc.
  • Fujirebio

Regional Overview

  • North America
  • Asia Pacific
  • Europe
  • Middle East and Africa
  • South and Central America

Market Segmentation

Type
  • One-Step qPCR and Two-Step qPCR
Product
  • Instruments
  • Reagents and Consumables
  • Software and Services
Application
  • Research
  • Clinical
  • Forensics
End User
  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Research Laboratories and Academic Institutes
  • Forensic Laboratories
  • Clinical Research Organizations
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Report Segmentation and Scope:

The quantitative PCR (qPCR) market analysis has been carried out by considering the following segments: type, product, application, end user, and geography. Based on type, the market is segmented into one-step qPCR and two-step qPCR. In terms of product, the market is classified into reagents and consumables, instruments, and software and services. By application, the market is segmented into research, clinical, and forensics. Based on end user, the market is categorized into hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, forensic laboratories, and clinical research organizations. The geographic scope of the quantitative PCR (qPCR) market report covers North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Segmental Analysis:

The quantitative PCR (qPCR) market, by type, is categorized into one-step qPCR and two-step qPCR. The two-step qPCR segment held a significant market share in 2023. It is anticipated to record a higher CAGR in the market during 2023–2031.

Based on product, the market is categorized into reagents and consumables, instruments, and software and services. The reagents and consumables segment held a significant quantitative PCR (qPCR) market share in 2023, and it is further estimated to register the highest CAGR during 2023–2031.

The quantitative PCR (qPCR) market, by application, is categorized into research, clinical, and forensics. The clinical segment held a significant market share in 2023. It is anticipated to record the highest CAGR in the market during 2023–2031.

Based on end user, the quantitative PCR (qPCR) market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held a significant market share in 2023 and is expected to register the highest CAGR during 2023–2031.

Regional Analysis:

In terms of geography, the quantitative PCR (qPCR) market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2023, North America captured a significant share of the market. In 2023, the US dominated the market in this region. The quantitative PCR (qPCR) market growth in North America is attributed to the extensive R&D conducted across various academic and research institutes, growing focus on employing advanced techniques and tools in healthcare, government and private initiatives and funds for promoting precision medicine as well as genomic research, upsurge in demand for innovative products from PCR companies, and presence of key market players.

In June 2020, Azure Biosystems launched Azure Cielo real-time PCR instrument. The Cielo is a 96-well qPCR machine that maintains the brand promise of compact design, high performance, and intuitive workflow. The Azure Biosystem's sensitivity and reliability have been devoted to genomics applications. The Cielo marks the first instrument dedicated to the genomics workflow for the company.

Industry Developments and Future Opportunities:

The quantitative PCR (qPCR) market report includes company positioning and concentration to evaluate the performance of competitors in the market. As per company press releases, below are a few initiatives taken by key players operating in the market:

  • In May 2023, Standard BioTools Inc. launched NGS library preparation functionality on the X9 High-Throughput Genomics System. With this launch, customers can run real-time PCR and NGS library preparation applications on a single benchtop system to support discovery through screening.
  • In March 2021, Agilent Technologies Inc introduced a real-time reverse transcription (qRT) PCR-based diagnostic kit for SARS-CoV-2 RNA detection. The Agilent SARS-CoV-2 qRT-PCR Dx kit is an in vitro diagnostic reagent kit for detecting SARS-CoV-2 RNA using qRT-PCR. The single-tube assay enables increased efficiency, higher throughput, less consumable usage, and unambiguous results for testing outcomes confidence.

Competitive Landscape and Key Companies:

The quantitative PCR (qPCR) market forecast can help stakeholders plan their growth strategies. Abbott Laboratories, Thermo Fisher Scientific Inc., Standard Biotools Inc., F. Hoffmann-la Roche Ltd, Qiagen, Lepu Medical Technology Beijing Co Ltd, Bio-rad Laboratories Inc., Takara Bio Inc., Agilent Technologies Inc., and Fujirebio are among the prominent players profiled in the market. These companies focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.

Quantitative PCR (qPCR) Market Report Scope

Report Attribute Details
Market size in 2023 US$ 2.57 Billion
Market Size by 2031 US$ 4.82 Billion
Global CAGR (2023 - 2031) 8.2%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • One-Step qPCR and Two-Step qPCR
By Product
  • Instruments
  • Reagents and Consumables
  • Software and Services
By Application
  • Research
  • Clinical
  • Forensics
By End User
  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Research Laboratories and Academic Institutes
  • Forensic Laboratories
  • Clinical Research Organizations
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Rest of Asia Pacific
Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Rest of Europe
Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East and Africa
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Standard Biotools Inc.
  • F. Hoffmann-la Roche Ltd
  • Qiagen
  • Lepu Medical Technology Beijing Co Ltd
  • Bio-rad Laboratories Inc.
  • Takara Bio Inc.
  • Agilent Technologies Inc.
  • Fujirebio
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Type, Product, Application, End User, and Geography

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What are the growth estimates for the quantitative PCR (qPCR) market till 2031?

    The quantitative PCR (qPCR) market is expected to be valued at US$ 4.82 billion in 2031.

    Which segment is dominating the quantitative PCR (qPCR) market?

    The global quantitative PCR (qPCR) market is segmented based on type, product, application, and end user. The quantitative PCR (qPCR) market, by type, is categorized into one-step qPCR and two-step qPCR. The two-step qPCR segment held a significant market share in 2023 and is anticipated to record the highest CAGR in the market during 2023–2031.

    What was the estimated quantitative PCR (qPCR) market size in 2023?

    The quantitative PCR (qPCR) market was valued at US$ 2.57 billion in 2023.

    Who are the major players in the quantitative PCR (qPCR) market?

    The quantitative PCR (qPCR) market majorly consists of the players, including Abbott Laboratories, Thermo Fisher Scientific Inc., Standard Biotools Inc., F. Hoffmann-la Roche Ltd, Qiagen, Lepu Medical Technology Beijing Co Ltd, Bio-rad Laboratories Inc., Takara Bio Inc., Agilent Technologies Inc., and Fujirebio.

    What are the driving and restraining factors for the quantitative PCR (qPCR) market?

    The factors driving the growth of the quantitative PCR (qPCR) market include the advancements in qPCR and the rising demand for qPCR systems in infectious disease detection. However, the high cost of real-time PCR systems hampers the growth of the quantitative PCR (qPCR) market.

    What is qPCR?

    Quantitative PCR (qPCR) quantifies the process of PCR amplification as the reaction proceeds. It is an extensively used diagnostic technique in diverse sectors such as research, pharmaceuticals, and biotechnology, offering a wide range of applications. Numerous research institutions and universities provide excellent assistance by providing qPCR platforms for doing various tests, one of the most accurate laboratory methods for identifying, tracking, and investigating the COVID-19 virus.

    The List of Companies - Quantitative PCR (qPCR) Market

    1. Abbott Laboratories
    2. Thermo Fisher Scientific Inc.
    3. Standard Biotools Inc.
    4. F. Hoffmann-la Roche Ltd
    5. Qiagen
    6. Lepu Medical Technology Beijing Co Ltd
    7. Bio-rad Laboratories Inc.
    8. Takara Bio Inc.
    9. Agilent Technologies Inc.
    10. Fujirebio.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Quantitative PCR (qPCR) Market